Precision Medicine

Payer Precision Medicine Program Covers At-Home Genetic Tests

April 13, 2022 - Blue Cross Blue Shield of Michigan is making at-home genetic testing available to members as part of a precision medicine approach to care. The payer will cover genetic testing through Blue Care Network, the company’s nonprofit health maintenance organization (HMO), which covers 840,000 members. “Our first priority with the Blue Cross...

Read More


More Articles

Obstacles to Covering Precision Medicine Multicancer Screenings

by Kelsey Waddill

While precision medicine multicancer screening tests could blaze a path to lower cancer-related costs and earlier cancer detection, these precision medicine tools face many hurdles to acquiring payer...

CMS Proposed Rule Redefines Payer Value-Based Payment Negotiations

by Kelsey Waddill

CMS has proposed a rule that allows payers to adopt new value-based payment models for gene therapies. “CMS’s rules for ensuring that Medicaid receives the lowest price available for...

3 Ways Payers Drive Population Health Management in Cancer Care

by Kelsey Waddill

The industry’s transition into value-based care is characterized by a focus on data and patient centered care. By driving strong population health management, payers can excel in this value-based...

CMS: Medicare Will Cover Genetic Diagnostics For Certain Cancers

by Kelsey Waddill

Medicare will now cover Next Generation Sequencing for beneficiaries with inherited ovarian or breast cancer in order to improve their precision medicine treatment options, CMS...

Finalized CMS Rule Supports Medicare Coverage for Acupuncture

by Samantha McGrail

CMS has finalized a proposed rule to provide Medicare coverage to chronic low back patients accessing acupuncture, which furthers the administration’s efforts to address the opioid...

Care Coordination and Precision Medicine Improve Early Diagnoses

by Kelsey Waddill

Payers are using coordinated care and precision medicine to make diagnoses more quickly and ensure a strong treatment plan for severe and chronic disease management. Early detection of chronic and...

BCBSA Shares Claims Data for Personalized Treatment Plans for MS

by Kelsey Waddill

Blue Cross Blue Shield Association (BCBSA) shares reports on claims data via the Health of America platform in the hopes that the information might lead to better personalized treatment plans. The...

Precision Medicine Challenges Persist, Aetna Leads Response

by Kelsey Waddill

Precision medicine has the potential to significantly improve health outcomes and save members and their payers, so Aetna is overcoming the major challenges associated with implementing the...

Centene Grants $100M to Washington University for Precision Medicine

by Jessica Kent

Centene will fund up to $100 million in precision medicine research at the Washington University School of Medicine in an effort to accelerate treatment for Alzheimer’s disease, breast cancer,...

Outcomes-Based Contracts Offer Payers New Pharmaceutical Options

by Thomas Beaton

Payers may be more willing to provide their beneficiaries with genetic drug therapies that costs hundreds of thousands of dollars if they enter into outcomes-based pharmaceutical contracts that lessen...

Recent Articles